What are senolytic drugs and what is their potential for treating age-related dysfunction and diseases?
Fisetin Senolytic Capsules (J Intern Med 2020, PMID 32686219) — senolytic drugs, which clear aging cells, show promise in preclinical studies for treating many age-related diseases, with human trials currently underway. No numeric effect size is reported for Fisetin Senolytic Capsules in the source abstract.
Source: J Intern Med 2020, PMID 32686219 ↗ · Research map · How Magellan grades evidence · evidence confidence: low
J Intern Med · 2020 · PMID 32686219 · DOI 10.1111/joim.13141
Senolytic drugs, which clear aging cells, show promise in preclinical studies for treating many age-related diseases, with human trials currently underway.
The question
What are senolytic drugs and what is their potential for treating age-related dysfunction and diseases?
What they tested
Senolytic drugs, by selectively clearing senescent cells, can delay, prevent, or alleviate various age-related disorders and conditions.
How they did it
This abstract reviews the discovery of senolytic drugs and summarizes findings from preclinical models and early pilot human trials.
What they found
The first senolytic drugs (Dasatinib, Quercetin, Fisetin, Navitoclax) were discovered using a hypothesis-driven approach. In preclinical models, senolytics alleviated over 40 conditions, including frailty, cancers, and various organ system disorders. Early human pilot trials suggest senolytics decrease senescent cells, reduce inflammation, and alleviate frailty.
What it means
Senolytics show promise in preclinical models for treating numerous age-related conditions by targeting senescent cells. Early human trials are encouraging, but more extensive clinical trials are needed before widespread use.
Limitations
The abstract notes that it is too early for senolytics to be used outside of clinical trials, indicating that current human data are preliminary and further research is required.
The paper at a glance
| Title | Senolytic drugs: from discovery to translation |
|---|---|
| Journal | J Intern Med |
| Year | 2020 |
| PMID | 32686219 ↗ |
| DOI | 10.1111/joim.13141 ↗ |
| Topic | Senescence, senolytics & the hallmarks of aging |
Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗
Where Magellan uses this paper
This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.
Fisetin Senolytic Capsules
Because senescent cells accumulate with age and contribute to frailty, vascular dysfunction, inflammation, and multiple age-related diseases, selectively clearing them is a leading longevity strategy.
Quercetin Capsules
Meta-analyses of randomized trials indicate quercetin produces a small blood-pressure reduction—on the order of 2–3 mmHg—most apparent at doses of at least 500 mg/day and in people with hypertension rather than normal blood pressure;
NOVOS Core is a multi-ingredient dietary supplement marketed for longevity that combines about a dozen…
Fisetin is a naturally occurring flavonol (a plant polyphenol) found in strawberries, apples…
Quercetin is a flavonol, a plant polyphenol found abundantly in onions, apples, berries, capers, and…
Research describes the compound or intervention studied. It is not a claim about any specific product.
Molecules & mechanisms in this paper
Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.
Cite this page
These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.
Magellan Longevity. (2026). What are senolytic drugs and what is their potential for treating age-related dysfunction and diseases? [Plain-English summary of J Intern Med 2020, PMID 32686219, DOI 10.1111/joim.13141]. Magellan Longevity. https://magellanlongevity.com/study/d32686219.html@misc{magellan_d32686219,
title = {What are senolytic drugs and what is their potential for treating age-related dysfunction and diseases?},
author = {{Magellan Longevity}},
year = {2026},
howpublished = {\url{https://magellanlongevity.com/study/d32686219.html}},
note = {Plain-English summary of PubMed PMID 32686219; DOI 10.1111/joim.13141; J Intern Med 2020. Reviewed by Gabriel Radu, DO},
urldate = {2026-08-11}
}https://magellanlongevity.com/study/d32686219.htmlRelated studies in the Magellan library
- Fisetin is a senotherapeutic that extends health and lifespanEBioMedicine · 2018 · PMID 30279143
- Cellular Senescence: A Translational PerspectiveEBioMedicine · 2017 · PMID 28416161
- Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levelsNutr Rev · 2020 · PMID 31940027
- Does quercetin supplementation affect systolic and diastolic blood pressure?Curr Probl Cardiol · 2022 · PMID 35948195
- Effects of Quercetin on Blood PressureJ Am Heart Assoc · 2016 · PMID 27405810
- Induction of autophagy by spermidine promotes longevityNature Cell Biology · 2009 · PMID 19801973
All 8 Magellan summaries on senescence, senolytics & the hallmarks of aging →
Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →